One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial.

One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial.

By: odddogmedia Date: May 1st, 2016

Stay Connected

Other Publications

More events you may be interested in.

Custom Link To Another Page Goes Here